Back to Search Start Over

Tocilizumab in Hospitalized Patients with COVID-19: A Meta Analysis of Randomized Controlled Trials

Authors :
Selvaraj, Vijairam
Khan, Mohammad Saud
Bavishi, Chirag
Dapaah-Afriyie, Kwame
Finn, Arkadiy
Lal, Amos
Mylonakis, Eleftherios
Source :
Lung. June, 2021, Vol. 199 Issue 3, p239, 10 p.
Publication Year :
2021

Abstract

Background To date, only dexamethasone has been shown to reduce mortality in coronavirus disease-19 (COVID-19) patients. Tocilizumab has been recently added to the treatment guidelines for hospitalized COVID-19 patients, but data remain conflicting. Study Design and Methods Electronic databases such as MEDLINE, EMBASE, and Cochrane central were searched from March 1, 2020, until March 10, 2021, for randomized controlled trials evaluating the efficacy of tocilizumab in hospitalized COVID-19 patients. The outcomes assessed were all-cause mortality, mechanical ventilation, and time to discharge. Results Nine studies (with 6490 patients) were included in the analysis. In total, 3358 patients received tocilizumab, and 3132 received standard care/placebo. Pooled analysis showed a significantly decreased risk of all-cause mortality (RR 0.89, 95% CI 0.80-0.98, p = 0.02) and progression to mechanical ventilation (RR 0.80, 95% CI 0.71-0.89, p < 0.0001) in the tocilizumab arm compared to standard therapy or placebo. In addition, there was a trend towards improved median time to hospital discharge (RR 1.28, 95% CI 1.12-1.45, p = 0.0002). Conclusions Tocilizumab therapy improves outcomes of mortality and need for mechanical ventilation, in hospitalized patients with COVID-19 infection compared with standard therapy or placebo. Our findings suggest the efficacy of tocilizumab therapy in hospitalized COVID-19 patients and strengthen the concept that tocilizumab is a promising therapeutic intervention to improve mortality and morbidity in COVID-19 patients.<br />Author(s): Vijairam Selvaraj [sup.1] [sup.2], Mohammad Saud Khan [sup.1] [sup.2], Chirag Bavishi [sup.2] [sup.3], Kwame Dapaah-Afriyie [sup.1] [sup.2], Arkadiy Finn [sup.1] [sup.2], Amos Lal [sup.4], Eleftherios Mylonakis [sup.2] [sup.5] Author [...]

Details

Language :
English
ISSN :
03412040
Volume :
199
Issue :
3
Database :
Gale General OneFile
Journal :
Lung
Publication Type :
Academic Journal
Accession number :
edsgcl.666288905
Full Text :
https://doi.org/10.1007/s00408-021-00451-9